tiprankstipranks
Cano Health downgraded to Peer Perform from Outperform at Wolfe Research
The Fly

Cano Health downgraded to Peer Perform from Outperform at Wolfe Research

Wolfe Research analyst Justin Lake downgraded Cano Health to Peer Perform from Outperform without a price target. The an last cites the company’s "challenging" capital position and lack of forward visibility for the downgrade. Heading into 2023, "the path forward for Cano is difficult to determine," Lake tells investors in a research note.

Published first on TheFly

See the top stocks recommended by analysts >>

Read More on CANO:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles